Back to discover
Disease

Amnesia

Active therapeutic pipelineEmerging researchRising momentum
MeSHAmnesia
3
Publications
7
Clinical trials
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 3 clinical trials with recent milestones (2 completed or reporting results).
  • 1 industry development reported.
Major developments
Major trial resultsHigh impact
Dose Response Effect of Nitrous Oxide on Amnesia in Healthy Children
Results posted2026-06-30
Major clinical milestoneImportant
Functional MRI of Nitrous Oxide Inhalation in Volunteer Subjects
Primary completion2026-09-01
Clinical Milestones3View
Results posted 1
Recently completed 2
Industry & Market1View
Activity timeline4

Clinical trials

6 sponsors · 0 new · 1 completed in the last 12 months (net +0)

The current development programme across all trial phases.

Clinical programme
7
All trials
1
Active
0
Late-stage
6
Completed
Recruiting

Functional MRI of Nitrous Oxide Inhalation in Volunteer Subjects

Early Phase 1 · Recruiting · Keith M Vogt
Recently completed

Sevoflurane's Effect on Neurocognition Study

Early Phase 1 · Completed · Keith M Vogt

Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers

Phase 1 · Completed · University of Wisconsin, Madison

Modulation of Long-term Memory by the Experience of Pain During Sedation With Anesthetics

Phase 1 · Completed · University of Pittsburgh

Transient Global Amnesia (TGA) Exploratory Study of the Default Mode Network in Resting State Functional MRI (fMRI) During the Acute Phase

N/A · Completed · University Hospital, Toulouse

Dose Response Effect of Nitrous Oxide on Amnesia in Healthy Children

N/A · Completed · State University of New York at Buffalo

Effect of Affective Content on Drug Induced Amnesia of Episodic Memory

Phase 1 · Completed · Memorial Sloan Kettering Cancer Center

Research activity

3 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20072024
Major themes6
  • Alzheimer Disease1
  • Amnesia1
  • Amyloidosis1
  • Memory1
  • Models, Psychological1
  • Neurodegenerative Diseases1
Leading journals3
  • Molecular psychiatry1
  • Neural plasticity1
  • The Journal of neuroscience : the official journal of the Society for Neuroscience1
Leading researchers8
  • Abebe D1
  • Burns MP1
  • Campbell AM1
  • Chapman DP1
  • Diamond DM1
  • Halonen J1
  • Loh YP1
  • Park CR1
Affiliations (unnormalised)6
  • Canadian Institute for Advanced Research (CIFAR)1
  • Center for Lifespan Psychology1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development1
  • Florey Institute of Neuroscience and Mental Health1
  • Georgetown University Medical Center1
  • School of Biochemistry and Immunology1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Pathologic partial or complete loss of the ability to recall past experiences (AMNESIA, RETROGRADE) or to form new memories (AMNESIA, ANTEROGRADE). This condition may be of organic or psychologic origin. Organic forms of amnesia are usually associated with dysfunction of the DIENCEPHALON or HIPPOCAMPUS. (From Adams et al., Principles of Neurology, 6th ed, pp426-7)

Identifiers
MeSHAmnesia
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.